Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review

Maes‐Carballo, Marta; Mignini, Luciano; Martín-Díaz, Manuel; Bueno‐Cavanillas, Aurora; Khan, Khalid S.

doi:10.1016/j.breast.2020.07.011

Cited by 17 publications

(27 citation statements)

References 60 publications

(117 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The standard was not comparable with the hypo fractionated radiation. The investigative subspecies investigation, hypo fractionation had all the earmarks of being less compelling for exceptional sarcoma comparing with poor-quality sarcoma [73]- [77]. The following experiments might be a successive result, yet this might rather mirror an alternate inalienable radiation affectability of superlative sarcoma or idiomatic subgroup of bosom malignant growth which were related to superlative sarcoma.…”

Section: Discussionmentioning

confidence: 99%

Extended Hypofractionated Cancer Radiation Therapy Against Aged and Non-aged Breast Carcinomas Patients

Khatun

Ahamed

2021

CLINICMED

View full text Add to dashboard Cite

We led an investigation to decide if hypo fractionated 35-days timetable of entire breast radiation is pretty much as viable. Women who bearing obtrusive breast carcinoma had gone through breast monitoring a medical procedure and resection edges were clean and partially lymph hubs were negatively approached with haphazardly relegated to get entire bosom illumination either at a control portion of 50 Gy in 15 divisions over a time of 45 days or at a portion of 45.5 Gy in 12 parts over a time of 22 days (the hypo fractionated-radiation bunch). The repetition at 36 months were 7.2% among the 301 ladies allocated to standard illumination as contrasted and 7.6% among the 312 ladies allocated to the hypo fractionated routine. At 36 months, 69.5% of ladies in the benchmark group as contrasted and 71.2% of the ladies in the hypo fractionated-radiation bunch had a decent or astounding restorative result. 3 years after therapy, sped up, hypo fractionated entire breast illumination was not sub-par compared to standard radiation therapy in ladies who had gone through breast preserving a medical procedure for obtrusive bosom malignant growth with clear careful edges what's more, negative axillary hubs. The ideal fractionation plan for entire bosom light after bosom rationing medical procedure is obscure.

show abstract

Section: Discussionmentioning

confidence: 99%

Extended Hypofractionated Cancer Radiation Therapy Against Aged and Non-aged Breast Carcinomas Patients

Khatun

Ahamed

2021

CLINICMED

View full text Add to dashboard Cite

show abstract

“…Each item was given a score from 1 (strongly disagree) to 7 (strongly agree). The overall quality scores ranged from 0% to 100%, and guidelines were classified as "high quality" if the AGREE II score was >80%, "moderate quality" if it was 50-80%, and "low quality" if <50% (14). Before the formal evaluation, all reviewers completed an online training tutorial to ensure standardization (10)(11)(12)(13).…”

Section: Quality Appraisal Of Guidelinesmentioning

confidence: 99%

“…The "reported" option was used when the relevant information was provided in the guideline, whereas "not reported" indicated that the relevant information could not be found or was unclear. The guidelines were classified as "well-reported" if the reporting rate was >80%, "moderate-reported" if it was 50-80%, and "low-reported" if <50% (14). Two rounds of pilot assessment of four guidelines were completed and the ICC value was calculated.…”

Section: Quality Appraisal Of Guidelinesmentioning

confidence: 99%

Quality and consistency of clinical practice guidelines for treating children with COVID-19

Li¹,

Zhou²,

Xun³

et al. 2021

Ann Transl Med

View full text Add to dashboard Cite

Background: The Coronavirus Disease 2019 (COVID-19) pandemic negatively affects children's health.Many guidelines have been developed for treating children with COVID-19. The quality of the existing guidelines and the consistency of recommendations remains unknown. Therefore, we aim to review the clinical practice guidelines (CPGs) for children with COVID-19 systematically.Methods: We systematically searched Medline, Embase, guideline-related websites, and Google. The Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool and Reporting Items for practice Guidelines in HealThcare (RIGHT) checklist were used to evaluate the methodological and reporting quality of the included guidelines, respectively. The consistency of recommendations across the guidelines and their supporting evidence were analyzed.Results: Twenty guidelines were included in this study. The mean AGREE II score and mean RIGHT reporting rate of the included guidelines were 37% (range, 22-62%) and 52% (range, 31-89%), respectively.As for methodological quality, no guideline was classified as high, one guideline (5%) moderate, and 19 (95%) low. In terms of reporting quality, one guideline (5%) was rated as high, 12 guidelines (60%) moderate, and seven (35%) low. Among included guidelines, recommendations varied greatly in the use of remdesivir

show abstract

“…[10][11][12] Despite widely recognised principles and methods for developing sound CPGs, current research shows that guidelines on various topics lack appropriate uptake of systematic review methodologies in their development, 13 give recommendations that conflict with scientific evidence 14 or do not adequately take into account existing CPG quality and reporting assessment tools. 15 This emphasises the ongoing need to appraise guidelines to ensure evidence-informed care.…”

Section: Introductionmentioning

confidence: 99%

International clinical practice guidelines for gender minority/trans people: systematic review and quality assessment

et al. 2021

View full text Add to dashboard Cite

ObjectivesTo identify and critically appraise published clinical practice guidelines (CPGs) regarding healthcare of gender minority/trans people.DesignSystematic review and quality appraisal using AGREE II (Appraisal of Guidelines for Research and Evaluation tool), including stakeholder domain prioritisation.SettingSix databases and six CPG websites were searched, and international key opinion leaders approached.ParticipantsCPGs relating to adults and/or children who are gender minority/trans with no exclusions due to comorbidities, except differences in sex development.InterventionAny health-related intervention connected to the care of gender minority/trans people.Main outcome measuresNumber and quality of international CPGs addressing the health of gender minority/trans people, information on estimated changes in mortality or quality of life (QoL), consistency of recommended interventions across CPGs, and appraisal of key messages for patients.ResultsTwelve international CPGs address gender minority/trans people’s healthcare as complete (n=5), partial (n=4) or marginal (n=3) focus of guidance. The quality scores have a wide range and heterogeneity whichever AGREE II domain is prioritised. Five higher-quality CPGs focus on HIV and other blood-borne infections (overall assessment scores 69%–94%). Six lower-quality CPGs concern transition-specific interventions (overall assessment scores 11%–56%). None deal with primary care, mental health or longer-term medical issues. Sparse information on estimated changes in mortality and QoL is conflicting. Consistency between CPGs could not be examined due to unclear recommendations within the World Professional Association for Transgender Health Standards of Care Version 7 and a lack of overlap between other CPGs. None provide key messages for patients.ConclusionsA paucity of high-quality guidance for gender minority/trans people exists, largely limited to HIV and transition, but not wider aspects of healthcare, mortality or QoL. Reference to AGREE II, use of systematic reviews, independent external review, stakeholder participation and patient facing material might improve future CPG quality.PROSPERO registration numberCRD42019154361.

show abstract

Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review

Cited by 17 publications

References 60 publications

Extended Hypofractionated Cancer Radiation Therapy Against Aged and Non-aged Breast Carcinomas Patients

Extended Hypofractionated Cancer Radiation Therapy Against Aged and Non-aged Breast Carcinomas Patients

Quality and consistency of clinical practice guidelines for treating children with COVID-19

International clinical practice guidelines for gender minority/trans people: systematic review and quality assessment

Contact Info

Product

Resources

About